PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 10, 2026BMC Endocrine Disorders0 citationsOpen Access

Continuous glucose monitoring reveals distinct clinical implications of glucose levels at the start and end of hemodialysis in people with type 2 diabetes

AHAkinori HayashiRTRIHITO TAKAESUHSHaruna Sogabe

Key Points

  • This research aims to explore the significance of glucose levels at the beginning and end of hemodialysis sessions in people with type 2 diabetes.
  • Continuous glucose monitoring during hemodialysis sessions
  • Comparison of glucose levels at the start and end of HD
  • Assessment of hypoglycemia risk based on end-of-HD glucose levels
  • End-of-HD glucose level is a strong indicator of hypoglycemia risk
  • Distinct clinical relevance of glucose levels at different session phases was established
  • Tailored monitoring strategies may improve glycemic risk assessment

Abstract

Glucose levels at the start and end of HD sessions demonstrate distinct clinical relevance. End-of-HD glucose level serves as a useful marker for hypoglycemia risk, highlighting the potential importance of tailored monitoring strategies to support glycemic risk assessment in this high-risk population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hayashi et al. (2026) studied this question.

synapsesocial.com/papers/69d892d16c1944d70ce04003https://doi.org/10.1186/s12902-026-02261-7
Ask AI
Helpful
Bookmark
Share
View Full Paper